Pharmaceuticals News

RANCHO CORDOVA, Californie, 30 sept. 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd’hui un plan d’investissement global de plus de 200 millions de dollars sur cinq ans destiné à étendre et...

RANCHO CORDOVA, Kalifornien, Sept. 30, 2026 (GLOBE NEWSWIRE) -- SK pharmteco hat heute einen umfassenden, auf fünf Jahre angelegten Investitionsplan mit einem Volumen von mehr als 200 Millionen...

미국 캘리포니아주 랜초 코도바, Oct. 01, 2026 (GLOBE NEWSWIRE) -- SK pharmteco가 저분자 의약품과 펩타이드 분야의 미국 내 개발 및 생산 인프라를 확충하고 고도화하기 위해 향후 5년간 2억 달러 이상을 투자하는 내용의 종합 투자 계획을 발표했다. 이번에 공개된 전략적 투자는 회복탄력적인 공급망을 확보하고 광범위한...

SK pharmteco to invest more than $200 million to expand and upgrade its U.S. development and manufacturing infrastructure for peptides and small molecules.

CJ Biomaterials secures BPI, TÜV AUSTRIA Certifications for New PHACT™ All-PHA Compound Designed for Home Compostable Cutlery

DALLAS, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced the launch of the first institutional credit facility on HyperLend’s...

Primary composite endpoint met: 61% of patients achieved visual and pathological response across all treated lesions.Complete clinical and pathological response in 56% of high-risk head & neck...

Addition of NVIDIA Nemotron models and Hermes runtime expands customer choice across both AI models and agent software SARASOTA, FLA., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO)...

LAS VEGAS, NEVADA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotech developing transformative cell-based therapies for diabetes,...

Company highlights supportive survival observations, potential for biomarker-driven patient selection and upcoming Phase 2 DURIPANC milestones Access it here OCALA, Fla., Sept. 30, 2026 (GLOBE...